Рыночная капитализация Изменить Дата
Akebia Therapeutics USD 427M 297M 2025-12
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Cspc Pharmaceutical CNY 103.79B 16.5B 2026-03
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 4.58B 2.8B 2026-03
Divis Laboratories Ltd INR 1.75T 167.78B 2026-06
Gilead Sciences USD 156.86B 16.13B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Kangmei Pharma CNY 24.48B 3.45B 2026-03
Karyopharm Therapeutics USD 126M 9M 2026-03
Laboratorios Farma EUR 4.17B 917.16M 2026-03
MacroGenics USD 184M 82M 2026-03
Malin Corporation EUR 133.52M 29.05M 2026-08
Medical Developments International AUD 62.53M 563.29K 2025-12
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Organigram Holdings CAD 252.47M 59.69M 2026-03
Ovoca Bio EUR 1.17M 18.38K 2025-12
Pfizer USD 138.44B 15.37B 2026-06
Pharma Mar EUR 1.31B 263.2M 2026-06
Qiagen NV USD 8.07B 197.36M 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
Sartorius EUR 15.63B 1.38B 2026-06
Takeda JPY 8.2T 809.7B 2026-06
Zealand Pharma A/S 20.84B 12.51B 2026-03
Zz Pientze Pharmaceu CNY 65.93B 25.23B 2026-06